
ABVX
Abivax SA
$97.82
+$2.19(+2.29%)
54
Overall
--
Value
75
Tech
34
Quality
Market Cap
$6.76B
Volume
1.01M
52W Range
$4.77 - $97.83
Target Price
$111.29
Order:
Income Statement
Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|
OPERATING EXPENSES | |||||
Operating Expenses | $55.8M | $132.0M | $185.4M | ||
Research & Development | $41.0M | $103.2M | $146.5M | ||
Research Expense | $41.0M | $103.2M | $146.5M | ||
Selling, General & Administrative | $10.3M | $28.8M | $38.9M | ||
Selling & Marketing Expenses | -- | $6.4M | $6.0M | ||
General & Administrative Expenses | $10.3M | $22.4M | $32.9M | ||
Salaries & Wages | $4.5M | $21.2M | -- | ||
OPERATING INCOME | |||||
Operating income | $-55.8M | $-132.0M | $-185.4M | ||
EBITDA | $-75.5M | $-119.2M | $-158.2M | ||
NON-OPERATING ITEMS | |||||
Interest Expense (Non-Operating) | $7.0M | $27.9M | $17.0M | ||
Interest Income Operating | -- | $4.6M | $12.4M | ||
Intinc | $-1.8M | $7.5M | $13.7M | ||
Net Non-Operating Interest Income/Expense | $-8.8M | $-20.4M | $-3.3M | ||
Other Income/Expense | $4.8M | $-5.8M | -- | ||
Other Special Charges | $4.6M | $4.8M | -- | ||
SPECIAL ITEMS | |||||
Special Income Charges | $-13.6M | -- | -- | ||
Impairment of Capital Assets | $13.6M | -- | -- | ||
PRE-TAX INCOME | |||||
EBIT | $-76.0M | $-119.9M | $-159.3M | ||
Pre-Tax Income | $-83.0M | $-147.7M | $-176.2M | ||
NET INCOME | |||||
Net Income | $-83.0M | $-147.7M | $-176.2M | ||
Net Income (Continuing Operations) | $-83.0M | $-147.7M | $-176.2M | ||
Net Income (Discontinued Operations) | $-83.0M | $-147.7M | $-176.2M | ||
Net Income (Common Stockholders) | $-83.0M | $-147.7M | $-176.2M | ||
Normalized Income | $-47.4M | $-108.6M | $-174.5M | ||
TOTALS | |||||
Total Expenses | $55.8M | $132.0M | $185.4M | ||
SHARE & EPS DATA | |||||
Average Shares Outstanding | $19.1M | $43.1M | $63.0M | ||
Average Shares Outstanding (Diluted) | $19.1M | $43.1M | $63.0M | ||
Shares Outstanding | $75.2M | $75.2M | $63.3M | ||
Basic EPS | $-3.18 | $-3.43 | $-2.8 | ||
Basic EPS (Continuing Operations) | $-3.18 | $-3.43 | $-2.8 | ||
Diluted EPS | $-3.18 | $-3.43 | $-2.8 | ||
Diluted EPS (Continuing Operations) | $-3.18 | $-3.43 | $-2.8 | ||
OTHER METRICS | |||||
Other Gand A | $10.3M | $22.4M | $32.9M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ABVX | $97.82 | +2.3% | 1.01M |
3 | ||||
4 | ||||
5 | ||||
6 |